E Cannabis Central's April Recap: 83% Of NPSI Constituents Went Up

Summary Of April Price Performance

  • 1 stock went UP more than 90%
    • Avicanna (AVCNF) +91.0%
  • 1 stock went UP between 80% and 89.9%
    • Greenlane (GNLN) +86.0%
  • 1 stock went UP between 70% and 79.9%
    • Neptune (NEPT) +78.6%
  • 1 stock went UP between 60% and 69.9%
    • Akerna (KERN) +63.1%
  • 2 stocks went UP between 40% and 49.9%
    • Rubicon (ROMJF) +47.3%; 
    • Medicine Man (SHWZ) +40.3%
  • 1 stock went UP between 30% and 39.9%
    • Cresco Labs Inc. (CRLBF) +32.9%
  • 5 stocks went UP between 20% and 29.9% 
  • 11 stocks went UP between 10% and 19.9%
  • 6 stocks went UP between 0.6% and 9.9%
  • 1 stock went DOWN between 0.1% and 4.9%
    • AYR Strategies (AYRSF) -1.3%
  • 2 stocks went DOWN between 5% and 9.9%
    • Acreage Holdings (ACRGF -7.3%
    • Valens GroWorks (VLNCF) -5.7% 
  • 1 stock went DOWN between 10% and 14.9%
    • FSD Pharma (HUGE) -14.0%
  • 1 stock went DOWN between 15% and 19.9%
    • Pyxus (PYX) -15.8%
  • 1 stock went DOWN more than 20% 
    • Organigram (OGI) -21.0%

The NPSI no longer includes Hexo (HEXO) and Aurora (ACB) as their stock prices have fallen below US$1/share, but they are worthy of mention and were -38.1% and -18.7%, respectively, for the month.

To see how the new Non-penny Pot Stock Index (NPSI) has done on a daily and weekly basis for the past few months, visit the Cannabis Central daily updates here.

1 2 3
View single page >> |

This article may discuss small-, micro- and nano-cap stocks so do your own careful due diligence. Visit   more

How did you like this article? Let us know so we can better customize your reading experience.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.